EX-23.1 24 d709743dex231.htm EX-23.1 EX-23.1

Exhibit 23.1


Consent of Independent Registered Public Accounting Firm


The Board of Directors

Karuna Therapeutics, Inc.:

We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ KPMG

Cambridge, Massachusetts

May 31, 2019